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Welcome to the Chicago Multidisciplinary Symposium in Thoracic Oncology
On behalf of ASTRO, ASCO, IASLC and the University of
Chicago, it is a pleasure to welcome you to the Chicago
Multidisciplinary Symposium in Thoracic Oncology (for-
merly the Chicago Symposium on Malignancies of the Chest
and Head and Neck). The symposium will bring together
physician specialists from North America and abroad to
discuss and share state-of-the art practices on an interdisci-
plinary approach for the treatment of thoracic cancers. The
scientific program will provide information on the latest
developments in basic and clinical research.
According to the American Cancer Society, over 200,000
Americans will learn they have lung cancer this year,
accounting for approximately 15% of cancer diagnoses.
More Americans die each year from lung cancer than from
breast, prostate and colorectal cancers combined (www.
lungcancer.org). Surgery, chemotherapy and radiation
therapy are typically used to treat lung cancer. A multi-
disciplinary meeting will promote interaction among these
disciplines in order to achieve the best possible outcome
for the patient.
A prestigious international teaching faculty has been assem-
bled to promote dialogue on topics such as mesothelioma,
personalized chemotherapy, experimental therapeutics and
new drug development relating to thoracic cancers. During
the course of the 3-day meeting, registrants will have an
opportunity to attend educational sessions and view the latest
clinical and research findings in both formal and informal oral
and poster sessions.
The goal for this symposium is to advance our knowledge in
thoracic cancers so as to further improve care opportunities
for cancer patients now and in the future.
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